DrugPatentWatch Database Preview
Mission Pharmacal Co Company Profile
Email this page to a colleague
What is the competitive landscape for MISSION PHARMACAL CO, and what generic and branded alternatives to MISSION PHARMACAL CO drugs are available?
MISSION PHARMACAL CO has three approved drugs.
Summary for Mission Pharmacal Co
| US Patents: | 0 |
| Tradenames: | 3 |
| Ingredients: | 3 |
| NDAs: | 3 |
| Drug Master File Entries: | 2 |
Drugs and US Patents for Mission Pharmacal Co
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mission Pharmacal Co | POTASSIUM IODIDE | potassium iodide | SOLUTION;ORAL | 206211-001 | Mar 24, 2016 | OTC | No | No | ⤷ Free Forever Trial | ⤷ Free Forever Trial | |||||
| Mission Pharmacal Co | CARBINOXAMINE MALEATE | carbinoxamine maleate | TABLET;ORAL | 090756-001 | May 27, 2011 | AA | RX | No | No | ⤷ Free Forever Trial | ⤷ Free Forever Trial | ||||
| Mission Pharmacal Co | THIOLA EC | tiopronin | TABLET, DELAYED RELEASE;ORAL | 211843-002 | Jun 28, 2019 | RX | Yes | Yes | ⤷ Free Forever Trial | ⤷ Free Forever Trial | |||||
| Mission Pharmacal Co | THIOLA EC | tiopronin | TABLET, DELAYED RELEASE;ORAL | 211843-001 | Jun 28, 2019 | RX | Yes | No | ⤷ Free Forever Trial | ⤷ Free Forever Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
